Joint Progression Modeling (JPM): A Probabilistic Framework for Mixed-Pathology Progression
Hongtao Hao, Joseph L. Austerweil
TL;DR
The paper introduces the Joint Progression Model (JPM) to address mixed-pathology progression in neurodegenerative diseases by reframing single-disease trajectories as partial rankings and placing a probabilistic, energy-based prior over joint progressions. It formalizes four ranking-based variants (Pairwise Preferences, Generalized Bradley–Terry, Plackett–Luce, and a BT-informed Mallows) and develops generative and inferential algorithms to recover aggregate progression from cross-sectional data, integrating with an existing Event-Based Model likelihood. Through extensive synthetic experiments, JPM demonstrates up to ~21% improvements in ordering accuracy over SA-EBM and shows variant-specific strengths, with the Mallows variant offering controllable sharpness. Real-data analysis on NACC aligns Mallows and SA-EBM with established literature on AD and VaD progression, while providing practical guidance on variant selection based on input ranking characteristics. Overall, JPM provides a principled, flexible framework for joint disease progression, enabling better understanding and simulation of mixed-pathology dynamics.
Abstract
Event-based models (EBMs) infer disease progression from cross-sectional data, and standard EBMs assume a single underlying disease per individual. In contrast, mixed pathologies are common in neurodegeneration. We introduce the Joint Progression Model (JPM), a probabilistic framework that treats single-disease trajectories as partial rankings and builds a prior over joint progressions. We study several JPM variants (Pairwise, Bradley-Terry, Plackett-Luce, and Mallows) and analyze three properties: (i) calibration -- whether lower model energy predicts smaller distance to the ground truth ordering; (ii) separation -- the degree to which sampled rankings are distinguishable from random permutations; and (iii) sharpness -- the stability of sampled aggregate rankings. All variants are calibrated, and all achieve near-perfect separation; sharpness varies by variant and is well-predicted by simple features of the input partial rankings (number and length of rankings, conflict, and overlap). In synthetic experiments, JPM improves ordering accuracy by roughly 21 percent over a strong EBM baseline (SA-EBM) that treats the joint disease as a single condition. Finally, using NACC, we find that the Mallows variant of JPM and the baseline model (SA-EBM) have results that are more consistent with prior literature on the possible disease progression of the mixed pathology of AD and VaD.
